Mochida Pharmaceutical Co.,Ltd.
4534・Prime Market・Pharmaceuticals
Governance
The Board of Directors consists of 11 members in total, comprising 7 internal directors and 4 outside directors (the company has a Board of Corporate Auditors). It has adopted an executive officer system to accelerate management decision-making and business execution, and has established a Personnel and Compensation Committee, in which independent outside directors hold a majority, as an advisory body to the Representative Director.
Risk Management
The company has established a company-wide risk management framework based on the "Mochida Pharmaceutical Group Risk Management Regulations," and has set up a "Risk Management Committee" (meeting twice a year, chaired by the officer in charge of planning and administration) to deliberate on and oversee key risks, including sustainability-related risks. The status of its activities is reported to the Board of Directors at least once a year.
Shareholder Returns
The company aims to maintain a dividend per share of ¥80 or more during the FY25-27 medium-term management plan period. The annual dividend for FY2026 (ending March 2026) is ¥80 per share (interim ¥40, year-end ¥40), with a payout ratio of 35.9%. For FY2027 (ending March 2027), the annual dividend is planned to increase to ¥85 (interim ¥42.5).
Dividend Policy
The basic policy is to maintain stable dividends while enhancing internal reserves in preparation for future business development, while also recognizing the importance of profit distribution in line with earnings, in determining dividends. The company aims to maintain a dividend per share of ¥80 or more during the FY25-27 medium-term management plan period. The annual dividend for FY2026 (ending March 2026) is ¥80 per share (interim ¥40, year-end ¥40), with total dividends of ¥2,835 million and a payout ratio of 35.9%. For FY2027 (ending March 2027), an annual ordinary dividend of ¥85 per share (interim ¥42.5) is planned. Internal reserves are used for R&D, capital investment, business alliances, etc. The policy on share buybacks is to respond flexibly to changes in the business environment.
ESG
The company discloses climate change risks and opportunities in line with TCFD recommendations, targeting a 46% reduction in CO2 emissions by FY2030 compared to FY2013 levels (FY2024 actual: -27.6%), and aims for carbon neutrality by 2050. In terms of human capital, it has set targets of raising the proportion of female managers to 20% or more (by March 2031) and achieving a 100% childcare leave utilization rate for both men and women, integrating ESG issues into management through the Sustainability Committee and Risk Management Committee.
Last updated: June 24, 2026